Search Results 581-590 of 2499 for ☃[광고텔레:SEOGOT] 구글파워볼광고 구글슬롯커뮤니티광고 구글토토사이트홍보 룸싸롱홍보 검색상위노출광고 오피사이트홍보☃

  1. Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102) - Mayo Clinic

    Arm 1: Reduced intensity conditioning allogeneic hematopoietic cell transplantation (RIC-alloHCT),. Arm 2: Non-Transplant Therapy/Best Supportive Care.

  2. AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL - Mayo Clinic

    About this study. This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of AZD0486 monotherapy in adult ...

  3. Determining Rate of Change in Corneal Clearance of Scleral Lenses in Habitual Lens Wearer - Mayo Clinic

    (Compare to temporal pneumatonometer and Goldmann IOP after lens removal.), and evaluate tear exchange during scleral lens wear by observation and by assessing ...

  4. Remote Blood Biomarker Monitoring in Frontotemporal Lobar Degeneration - Mayo Clinic

    The purpose of this study is to collect and analyze blood specimens from individuals carrying known familial frontotemporal lobar degeneration (f-FTLD) ...

  5. Duplex Ultrasonography to Identify Reduced Dialysis Access Blood Flow that May Potentially Threaten Function and Patency of Arteriovenous Fistula or Graft - Mayo Clinic

    The purpose of this study is early identification of reduced arteriovenous fistula and Graft blood flow by Doppler ultrasound and evaluation of doppler US as a ...

  6. A Study of the Safety and Effectiveness of Atezolizumab Combined with Etoposide, and Carboplatin for Patients with Untreated Extensive-Stage Small Cell Lung Cancer - Mayo Clinic

    About this study. This randomized, Phase I/III, multicenter, double-blinded, placebo-controlled study is designed to evaluate the safety and efficacy of ...

  7. A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection - Mayo Clinic

    About this study. Subjects will receive an oral dose of SER-109 in 4 capsules once daily for 3 consecutive days in Treatment Group I or matching placebo ...

  9. Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301 - Mayo Clinic

    The primary objective of this study is to determine whether etripamil nasal spray (NS) 70 mg is superior to placebo at terminating episodes of PSVT in an ...

  10. A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1 - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...